New Zealand markets close in 4 hours 22 minutes

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
116.89+0.38 (+0.33%)
At close: 04:02PM EST
116.93 +0.04 (+0.03%)
After hours: 06:17PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 5209.78B
Enterprise value 3278.25B
Trailing P/E 28.66
Forward P/E 18.56
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)3.82
Price/book (mrq)15.48
Enterprise value/revenue 35.04
Enterprise value/EBITDA 715.21

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 311.41%
S&P500 52-week change 326.87%
52-week high 3121.53
52-week low 3101.55
50-day moving average 3111.78
200-day moving average 3112.19

Share statistics

Avg vol (3-month) 37.24M
Avg vol (10-day) 34.73M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.75B
% held by insiders 10.12%
% held by institutions 168.13%
Shares short (14 Nov 2021) 414.09M
Short ratio (14 Nov 2021) 42.43
Short % of float (14 Nov 2021) 40.80%
Short % of shares outstanding (14 Nov 2021) 40.80%
Shares short (prior month 14 Oct 2021) 411.49M

Dividends & splits

Forward annual dividend rate 45.64
Forward annual dividend yield 44.84%
Trailing annual dividend rate 35.20
Trailing annual dividend yield 34.46%
5-year average dividend yield 44.26
Payout ratio 4122.71%
Dividend date 314 Feb 2022
Ex-dividend date 412 Jan 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 13.66%
Operating margin (ttm)36.70%

Management effectiveness

Return on assets (ttm)8.48%
Return on equity (ttm)52.25%

Income statement

Revenue (ttm)55.17B
Revenue per share (ttm)31.19
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)31.75B
EBITDA 28.85B
Net income avi to common (ttm)7.46B
Diluted EPS (ttm)4.20
Quarterly earnings growth (yoy)37.70%

Balance sheet

Total cash (mrq)12.25B
Total cash per share (mrq)6.93
Total debt (mrq)80.74B
Total debt/equity (mrq)594.66
Current ratio (mrq)1.01
Book value per share (mrq)7.66

Cash flow statement

Operating cash flow (ttm)22.56B
Levered free cash flow (ttm)20.34B